default search action

combined dblp search
author search
venue search
publication search

ask others

"The Brain Tumor Segmentation (BraTS) Challenge 2023: Focus on Pediatrics ..."

Anahita Fathi Kazerooni et al. (2023)

> Home

Details and statistics

DOI: 10.48550/ARXIV.2305.17033

access: open

type: Informal or Other Publication

metadata version: 2024-10-06

- view
  - electronic edition via DOI (open access)
  authority control:
- export record
  dblp key:
  - journals/corr/abs-2305-17033
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/corr/abs-2305-17033
Anahita Fathi Kazerooni, Nastaran Khalili, Xinyang Liu, Debanjan Haldar, Zhifan Jiang, Syed Muhammad Anwar, Jake Albrecht, Maruf Adewole, Udunna Anazodo, Hannah Anderson, Sina Bagheri, Ujjwal Baid, Timothy Bergquist, Evan Calabrese, Verena Chung, Gian Marco Conte, Farouk Dako, James A. Eddy, Ivan Ezhov, Ariana Familiar, Keyvan Farahani, Shuvanjan Haldar, Juan Eugenio Iglesias, Anastasia Janas, Elaine Johanson, Florian Kofler, Dominic LaBella, Koen Van Leemput, Hongwei Bran Li, Nazanin Maleki, Zeke Meier, Bjoern H. Menze, Ahmed W. Moawad, Marie Piraud, Tina Poussaint, Zachary Reitman, Jeffrey D. Rudie, Ibraheem Salman Shaikh, Russell Taki Shinohara, Wenxin Tu, Karthik Viswanathan, Chunhao Wang, Jeffrey B. Ware, Benedikt Wiestler, Walter I. Wiggins, Anna Zapaishchykova, Mariam Aboian, Miriam Bornhorst, Peter de Blank, Michelle Deutsch, Maryam Fouladi, Lindsey Hoffman, Benjamin H. Kann, Margot Lazow, Leonie Mikael, Ali Nabavizadeh, Roger J. Packer, Adam C. Resnick, Brian Rood, Arastoo Vossough, Spyridon Bakas, Marius George Linguraru:
The Brain Tumor Segmentation (BraTS) Challenge 2023: Focus on Pediatrics (CBTN-CONNECT-DIPGR-ASNR-MICCAI BraTS-PEDs). CoRR abs/2305.17033 (2023)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.